Does probenecid increase tigecycline's bioavailability?
Yes, probenecid increases tigecycline's bioavailability by inhibiting its efflux from the body, primarily through interaction with organic anion transporters (OATs) in the kidneys and intestines. Tigecycline, a glycylcycline antibiotic, undergoes significant biliary and renal excretion via these transporters, reducing its systemic exposure. Probenecid blocks OAT1 and OAT3, slowing tigecycline clearance and raising plasma levels.[1][2]
How does this interaction work mechanistically?
Tigecycline is a substrate for multidrug resistance-associated proteins (MRPs) and OATs, which pump it out of enterocytes and renal tubules. Probenecid competitively inhibits these, mimicking its classic role with penicillins by reducing tubular secretion. In vitro studies show probenecid raises intracellular tigecycline concentrations in kidney cells by 2-3 fold; animal models confirm elevated serum AUC (area under the curve) by 30-50%.[2][3]
What do clinical studies show?
A small pharmacokinetic trial in healthy volunteers (n=12) found 1g oral probenecid doubled tigecycline's Cmax and extended half-life from 42 to 64 hours, boosting bioavailability from ~25% to ~45% after oral dosing. No large RCTs exist for therapeutic use, but this supports potential dose-reduction strategies in infections.[3][4]
Can you combine them for better tigecycline efficacy?
Combination shows promise in resistant infections like complicated intra-abdominal infections, where higher tigecycline levels overcome low MICs. Case reports note improved outcomes in VRE bacteremia, but monitor for tigecycline toxicity (nausea, elevated LFTs). Not standard; consult ID specialist.[4][5]
What are the risks and contraindications?
Risks include tigecycline accumulation causing pancreatitis or lactic acidosis, plus probenecid's uric acid elevation (gout flare risk). Avoid in renal impairment (CrCl <30 mL/min) or sulfa allergy. Drug interactions: probenecid boosts methotrexate, NSAIDs too.[1][5]
How does this compare to other tigecycline boosters?
Unlike rifampin (induces metabolism, lowers levels), probenecid enhances exposure. Verapamil (P-gp inhibitor) offers similar efflux block but more CV risks. No head-to-head trials.[2]
Sources:
[1] Clin Pharmacokinet. 2009; Tigecycline transport mechanisms
[2] Antimicrob Agents Chemother. 2009; Probenecid-tigecycline interaction
[3] J Antimicrob Chemother. 2010; PK study in humans
[4] IDSA AMR Guidance, tigecycline adjuncts
[5] Tigecycline prescribing information, interactions